Summit Therapeutics Inc. (SMMT) Stock Competitors & Peer Comparison
See (SMMT) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SMMT | $13.94 | -0.92% | 10.7B | -8.65 | -$1.59 | N/A |
| VRTX | $458.45 | -0.12% | 114.6B | 26.79 | $16.86 | N/A |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| REGN | $602.06 | -0.97% | 62.8B | 14.90 | $40.94 | +0.60% |
| ARGX | $902.99 | +1.20% | 54.3B | 39.03 | $22.49 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $279.44 | -1.16% | 37.1B | 70.05 | $3.97 | N/A |
| RVMDW | $7.12 | +11.17% | 35.4B | N/A | N/A | N/A |
| RVMD | $165.69 | +5.02% | 34.7B | -22.92 | -$7.11 | N/A |
| MRNA | $59.03 | -4.48% | 25.4B | -7.86 | -$8.14 | N/A |
Stock Comparison
SMMT vs VRTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, VRTX has a market cap of 114.6B. Regarding current trading prices, SMMT is priced at $13.94, while VRTX trades at $458.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas VRTX's P/E ratio is 26.79. In terms of profitability, SMMT's ROE is -3.41%, compared to VRTX's ROE of +0.24%. Regarding short-term risk, SMMT is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check VRTX's competition here
SMMT vs VRNA Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, SMMT is priced at $13.94, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas VRNA's P/E ratio is -102.80. In terms of profitability, SMMT's ROE is -3.41%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, SMMT is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check VRNA's competition here
SMMT vs REGN Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, REGN has a market cap of 62.8B. Regarding current trading prices, SMMT is priced at $13.94, while REGN trades at $602.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas REGN's P/E ratio is 14.90. In terms of profitability, SMMT's ROE is -3.41%, compared to REGN's ROE of +0.14%. Regarding short-term risk, SMMT is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check REGN's competition here
SMMT vs ARGX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ARGX has a market cap of 54.3B. Regarding current trading prices, SMMT is priced at $13.94, while ARGX trades at $902.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ARGX's P/E ratio is 39.03. In terms of profitability, SMMT's ROE is -3.41%, compared to ARGX's ROE of +0.37%. Regarding short-term risk, SMMT is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ARGX's competition here
SMMT vs SGEN Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, SMMT is priced at $13.94, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas SGEN's P/E ratio is -57.19. In terms of profitability, SMMT's ROE is -3.41%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, SMMT is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check SGEN's competition here
SMMT vs ALNY Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ALNY has a market cap of 37.1B. Regarding current trading prices, SMMT is priced at $13.94, while ALNY trades at $279.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ALNY's P/E ratio is 70.05. In terms of profitability, SMMT's ROE is -3.41%, compared to ALNY's ROE of +0.98%. Regarding short-term risk, SMMT is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ALNY's competition here
SMMT vs RVMDW Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RVMDW has a market cap of 35.4B. Regarding current trading prices, SMMT is priced at $13.94, while RVMDW trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RVMDW's P/E ratio is N/A. In terms of profitability, SMMT's ROE is -3.41%, compared to RVMDW's ROE of -0.83%. Regarding short-term risk, SMMT is less volatile compared to RVMDW. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check RVMDW's competition here
SMMT vs RVMD Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RVMD has a market cap of 34.7B. Regarding current trading prices, SMMT is priced at $13.94, while RVMD trades at $165.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RVMD's P/E ratio is -22.92. In terms of profitability, SMMT's ROE is -3.41%, compared to RVMD's ROE of -0.83%. Regarding short-term risk, SMMT is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check RVMD's competition here
SMMT vs MRNA Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, MRNA has a market cap of 25.4B. Regarding current trading prices, SMMT is priced at $13.94, while MRNA trades at $59.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas MRNA's P/E ratio is -7.86. In terms of profitability, SMMT's ROE is -3.41%, compared to MRNA's ROE of -0.37%. Regarding short-term risk, SMMT is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check MRNA's competition here
SMMT vs BNTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, BNTX has a market cap of 23B. Regarding current trading prices, SMMT is priced at $13.94, while BNTX trades at $90.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas BNTX's P/E ratio is -15.46. In terms of profitability, SMMT's ROE is -3.41%, compared to BNTX's ROE of -0.07%. Regarding short-term risk, SMMT is more volatile compared to BNTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check BNTX's competition here
SMMT vs RPRX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RPRX has a market cap of 22.8B. Regarding current trading prices, SMMT is priced at $13.94, while RPRX trades at $53.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RPRX's P/E ratio is 27.87. In terms of profitability, SMMT's ROE is -3.41%, compared to RPRX's ROE of +0.13%. Regarding short-term risk, SMMT is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check RPRX's competition here
SMMT vs UTHR Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, UTHR has a market cap of 22.8B. Regarding current trading prices, SMMT is priced at $13.94, while UTHR trades at $535.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas UTHR's P/E ratio is 19.85. In terms of profitability, SMMT's ROE is -3.41%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, SMMT is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check UTHR's competition here
SMMT vs ROIV Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ROIV has a market cap of 22.6B. Regarding current trading prices, SMMT is priced at $13.94, while ROIV trades at $31.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ROIV's P/E ratio is -58.20. In terms of profitability, SMMT's ROE is -3.41%, compared to ROIV's ROE of -0.07%. Regarding short-term risk, SMMT is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ROIV's competition here
SMMT vs INSM Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, INSM has a market cap of 20.8B. Regarding current trading prices, SMMT is priced at $13.94, while INSM trades at $97.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas INSM's P/E ratio is -16.63. In terms of profitability, SMMT's ROE is -3.41%, compared to INSM's ROE of -1.30%. Regarding short-term risk, SMMT is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check INSM's competition here
SMMT vs BGNE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, SMMT is priced at $13.94, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas BGNE's P/E ratio is -22.55. In terms of profitability, SMMT's ROE is -3.41%, compared to BGNE's ROE of +0.12%. Regarding short-term risk, SMMT is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check BGNE's competition here
SMMT vs INCY Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, INCY has a market cap of 19.6B. Regarding current trading prices, SMMT is priced at $13.94, while INCY trades at $101.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas INCY's P/E ratio is 13.87. In terms of profitability, SMMT's ROE is -3.41%, compared to INCY's ROE of +0.29%. Regarding short-term risk, SMMT is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check INCY's competition here
SMMT vs DNA-WT Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, SMMT is priced at $13.94, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, SMMT's ROE is -3.41%, compared to DNA-WT's ROE of -0.57%. Regarding short-term risk, SMMT is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check DNA-WT's competition here
SMMT vs NBIX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, NBIX has a market cap of 15.9B. Regarding current trading prices, SMMT is priced at $13.94, while NBIX trades at $159.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas NBIX's P/E ratio is 24.31. In terms of profitability, SMMT's ROE is -3.41%, compared to NBIX's ROE of +0.22%. Regarding short-term risk, SMMT is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check NBIX's competition here
SMMT vs GMAB Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, GMAB has a market cap of 15.5B. Regarding current trading prices, SMMT is priced at $13.94, while GMAB trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas GMAB's P/E ratio is 19.29. In terms of profitability, SMMT's ROE is -3.41%, compared to GMAB's ROE of +0.15%. Regarding short-term risk, SMMT is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check GMAB's competition here
SMMT vs ASND Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ASND has a market cap of 14.3B. Regarding current trading prices, SMMT is priced at $13.94, while ASND trades at $230.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ASND's P/E ratio is 26.29. In terms of profitability, SMMT's ROE is -3.41%, compared to ASND's ROE of -56.42%. Regarding short-term risk, SMMT is more volatile compared to ASND. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ASND's competition here
SMMT vs JAZZ Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, JAZZ has a market cap of 14.1B. Regarding current trading prices, SMMT is priced at $13.94, while JAZZ trades at $225.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas JAZZ's P/E ratio is 2042.36. In terms of profitability, SMMT's ROE is -3.41%, compared to JAZZ's ROE of +0.01%. Regarding short-term risk, SMMT is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check JAZZ's competition here
SMMT vs EXEL Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, EXEL has a market cap of 13B. Regarding current trading prices, SMMT is priced at $13.94, while EXEL trades at $51.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas EXEL's P/E ratio is 17.19. In terms of profitability, SMMT's ROE is -3.41%, compared to EXEL's ROE of +0.40%. Regarding short-term risk, SMMT is less volatile compared to EXEL. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check EXEL's competition here
SMMT vs BBIO Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, BBIO has a market cap of 13B. Regarding current trading prices, SMMT is priced at $13.94, while BBIO trades at $67.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas BBIO's P/E ratio is -17.72. In terms of profitability, SMMT's ROE is -3.41%, compared to BBIO's ROE of +0.36%. Regarding short-term risk, SMMT is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check BBIO's competition here
SMMT vs AXSM Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, AXSM has a market cap of 12.9B. Regarding current trading prices, SMMT is priced at $13.94, while AXSM trades at $250.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas AXSM's P/E ratio is -67.16. In terms of profitability, SMMT's ROE is -3.41%, compared to AXSM's ROE of -2.60%. Regarding short-term risk, SMMT is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check AXSM's competition here
SMMT vs KRTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, SMMT is priced at $13.94, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas KRTX's P/E ratio is -28.09. In terms of profitability, SMMT's ROE is -3.41%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, SMMT is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check KRTX's competition here
SMMT vs IONS Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, IONS has a market cap of 12.2B. Regarding current trading prices, SMMT is priced at $13.94, while IONS trades at $74.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas IONS's P/E ratio is -36.88. In terms of profitability, SMMT's ROE is -3.41%, compared to IONS's ROE of -0.59%. Regarding short-term risk, SMMT is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check IONS's competition here
SMMT vs MDGL Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, MDGL has a market cap of 11.7B. Regarding current trading prices, SMMT is priced at $13.94, while MDGL trades at $506.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas MDGL's P/E ratio is -37.52. In terms of profitability, SMMT's ROE is -3.41%, compared to MDGL's ROE of -0.50%. Regarding short-term risk, SMMT is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check MDGL's competition here
SMMT vs ARWR Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ARWR has a market cap of 11.5B. Regarding current trading prices, SMMT is priced at $13.94, while ARWR trades at $82.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ARWR's P/E ratio is -36.04. In terms of profitability, SMMT's ROE is -3.41%, compared to ARWR's ROE of -0.55%. Regarding short-term risk, SMMT is more volatile compared to ARWR. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ARWR's competition here
SMMT vs RNAM Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, SMMT is priced at $13.94, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RNAM's P/E ratio is -17.39. In terms of profitability, SMMT's ROE is -3.41%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, SMMT is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check RNAM's competition here
SMMT vs BMRN Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, BMRN has a market cap of 10.6B. Regarding current trading prices, SMMT is priced at $13.94, while BMRN trades at $55.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas BMRN's P/E ratio is 39.35. In terms of profitability, SMMT's ROE is -3.41%, compared to BMRN's ROE of +0.04%. Regarding short-term risk, SMMT is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check BMRN's competition here
SMMT vs KRYS Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, KRYS has a market cap of 10.3B. Regarding current trading prices, SMMT is priced at $13.94, while KRYS trades at $351.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas KRYS's P/E ratio is 46.53. In terms of profitability, SMMT's ROE is -3.41%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, SMMT is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check KRYS's competition here
SMMT vs CYTK Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CYTK has a market cap of 9.8B. Regarding current trading prices, SMMT is priced at $13.94, while CYTK trades at $78.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CYTK's P/E ratio is -11.50. In terms of profitability, SMMT's ROE is -3.41%, compared to CYTK's ROE of +1.40%. Regarding short-term risk, SMMT is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CYTK's competition here
SMMT vs RXDX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, SMMT is priced at $13.94, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RXDX's P/E ratio is -56.47. In terms of profitability, SMMT's ROE is -3.41%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, SMMT is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check RXDX's competition here
SMMT vs NUVL Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, NUVL has a market cap of 9.1B. Regarding current trading prices, SMMT is priced at $13.94, while NUVL trades at $123.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas NUVL's P/E ratio is -20.37. In terms of profitability, SMMT's ROE is -3.41%, compared to NUVL's ROE of -0.43%. Regarding short-term risk, SMMT is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check NUVL's competition here
SMMT vs TECH Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, TECH has a market cap of 9.1B. Regarding current trading prices, SMMT is priced at $13.94, while TECH trades at $56.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas TECH's P/E ratio is 82.77. In terms of profitability, SMMT's ROE is -3.41%, compared to TECH's ROE of +0.05%. Regarding short-term risk, SMMT is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check TECH's competition here
SMMT vs IMGN Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, SMMT is priced at $13.94, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas IMGN's P/E ratio is -111.55. In terms of profitability, SMMT's ROE is -3.41%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, SMMT is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check IMGN's competition here
SMMT vs CORT Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CORT has a market cap of 8.6B. Regarding current trading prices, SMMT is priced at $13.94, while CORT trades at $78.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CORT's P/E ratio is 228.31. In terms of profitability, SMMT's ROE is -3.41%, compared to CORT's ROE of +0.08%. Regarding short-term risk, SMMT is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check CORT's competition here
SMMT vs BPMC Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, SMMT is priced at $13.94, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas BPMC's P/E ratio is -51.58. In terms of profitability, SMMT's ROE is -3.41%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, SMMT is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check BPMC's competition here
SMMT vs CERE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, SMMT is priced at $13.94, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CERE's P/E ratio is -16.47. In terms of profitability, SMMT's ROE is -3.41%, compared to CERE's ROE of -0.72%. Regarding short-term risk, SMMT is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CERE's competition here
SMMT vs TGTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, TGTX has a market cap of 8.1B. Regarding current trading prices, SMMT is priced at $13.94, while TGTX trades at $56.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas TGTX's P/E ratio is 18.61. In terms of profitability, SMMT's ROE is -3.41%, compared to TGTX's ROE of +0.87%. Regarding short-term risk, SMMT is less volatile compared to TGTX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check TGTX's competition here
SMMT vs HALO Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, HALO has a market cap of 8.1B. Regarding current trading prices, SMMT is priced at $13.94, while HALO trades at $68.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas HALO's P/E ratio is 24.05. In terms of profitability, SMMT's ROE is -3.41%, compared to HALO's ROE of +1.26%. Regarding short-term risk, SMMT is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check HALO's competition here
SMMT vs IBRX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, IBRX has a market cap of 7.7B. Regarding current trading prices, SMMT is priced at $13.94, while IBRX trades at $7.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas IBRX's P/E ratio is -8.66. In terms of profitability, SMMT's ROE is -3.41%, compared to IBRX's ROE of +1.39%. Regarding short-term risk, SMMT is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check IBRX's competition here
SMMT vs ALKS Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ALKS has a market cap of 7.5B. Regarding current trading prices, SMMT is priced at $13.94, while ALKS trades at $45.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ALKS's P/E ratio is 49.99. In terms of profitability, SMMT's ROE is -3.41%, compared to ALKS's ROE of +0.09%. Regarding short-term risk, SMMT is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ALKS's competition here
SMMT vs KYMR Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, KYMR has a market cap of 7.4B. Regarding current trading prices, SMMT is priced at $13.94, while KYMR trades at $101.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas KYMR's P/E ratio is -25.26. In terms of profitability, SMMT's ROE is -3.41%, compared to KYMR's ROE of -0.25%. Regarding short-term risk, SMMT is less volatile compared to KYMR. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check KYMR's competition here
SMMT vs MTSR Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, SMMT is priced at $13.94, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas MTSR's P/E ratio is -23.58. In terms of profitability, SMMT's ROE is -3.41%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, SMMT is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check MTSR's competition here
SMMT vs PCVX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, PCVX has a market cap of 7.4B. Regarding current trading prices, SMMT is priced at $13.94, while PCVX trades at $51.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas PCVX's P/E ratio is -7.47. In terms of profitability, SMMT's ROE is -3.41%, compared to PCVX's ROE of -0.33%. Regarding short-term risk, SMMT is less volatile compared to PCVX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check PCVX's competition here
SMMT vs PTGX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, PTGX has a market cap of 7.3B. Regarding current trading prices, SMMT is priced at $13.94, while PTGX trades at $115.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas PTGX's P/E ratio is -62.35. In terms of profitability, SMMT's ROE is -3.41%, compared to PTGX's ROE of -0.18%. Regarding short-term risk, SMMT is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check PTGX's competition here
SMMT vs IMVT Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, IMVT has a market cap of 7.3B. Regarding current trading prices, SMMT is priced at $13.94, while IMVT trades at $38.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas IMVT's P/E ratio is -12.76. In terms of profitability, SMMT's ROE is -3.41%, compared to IMVT's ROE of -0.68%. Regarding short-term risk, SMMT is less volatile compared to IMVT. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check IMVT's competition here
SMMT vs MRUS Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, SMMT is priced at $13.94, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas MRUS's P/E ratio is -17.05. In terms of profitability, SMMT's ROE is -3.41%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, SMMT is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check MRUS's competition here
SMMT vs ACLX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, SMMT is priced at $13.94, while ACLX trades at $115.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ACLX's P/E ratio is -28.27. In terms of profitability, SMMT's ROE is -3.41%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, SMMT is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ACLX's competition here
SMMT vs RYTM Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RYTM has a market cap of 6.6B. Regarding current trading prices, SMMT is priced at $13.94, while RYTM trades at $98.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RYTM's P/E ratio is -30.92. In terms of profitability, SMMT's ROE is -3.41%, compared to RYTM's ROE of -2.03%. Regarding short-term risk, SMMT is more volatile compared to RYTM. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check RYTM's competition here
SMMT vs RETA Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, SMMT is priced at $13.94, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RETA's P/E ratio is -66.29. In terms of profitability, SMMT's ROE is -3.41%, compared to RETA's ROE of +0.47%. Regarding short-term risk, SMMT is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check RETA's competition here
SMMT vs PTCT Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, PTCT has a market cap of 6.6B. Regarding current trading prices, SMMT is priced at $13.94, while PTCT trades at $81.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas PTCT's P/E ratio is -31.09. In terms of profitability, SMMT's ROE is -3.41%, compared to PTCT's ROE of +1.00%. Regarding short-term risk, SMMT is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check PTCT's competition here
SMMT vs ABVX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ABVX has a market cap of 6.5B. Regarding current trading prices, SMMT is priced at $13.94, while ABVX trades at $98.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ABVX's P/E ratio is -18.53. In terms of profitability, SMMT's ROE is -3.41%, compared to ABVX's ROE of -1.65%. Regarding short-term risk, SMMT is more volatile compared to ABVX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ABVX's competition here
SMMT vs LQDA Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, LQDA has a market cap of 6.3B. Regarding current trading prices, SMMT is priced at $13.94, while LQDA trades at $73.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas LQDA's P/E ratio is 418.06. In terms of profitability, SMMT's ROE is -3.41%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, SMMT is less volatile compared to LQDA. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check LQDA's competition here
SMMT vs CNTA Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CNTA has a market cap of 6.2B. Regarding current trading prices, SMMT is priced at $13.94, while CNTA trades at $40.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CNTA's P/E ratio is -22.48. In terms of profitability, SMMT's ROE is -3.41%, compared to CNTA's ROE of -0.60%. Regarding short-term risk, SMMT is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CNTA's competition here
SMMT vs PRAX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, PRAX has a market cap of 6B. Regarding current trading prices, SMMT is priced at $13.94, while PRAX trades at $301.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas PRAX's P/E ratio is -21.07. In terms of profitability, SMMT's ROE is -3.41%, compared to PRAX's ROE of -0.43%. Regarding short-term risk, SMMT is less volatile compared to PRAX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check PRAX's competition here
SMMT vs COGT Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, COGT has a market cap of 5.9B. Regarding current trading prices, SMMT is priced at $13.94, while COGT trades at $35.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas COGT's P/E ratio is -15.92. In terms of profitability, SMMT's ROE is -3.41%, compared to COGT's ROE of -0.83%. Regarding short-term risk, SMMT is more volatile compared to COGT. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check COGT's competition here
SMMT vs BLTE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, BLTE has a market cap of 5.9B. Regarding current trading prices, SMMT is priced at $13.94, while BLTE trades at $146.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas BLTE's P/E ratio is -57.53. In terms of profitability, SMMT's ROE is -3.41%, compared to BLTE's ROE of -0.27%. Regarding short-term risk, SMMT is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check BLTE's competition here
SMMT vs SRRK Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, SRRK has a market cap of 5.7B. Regarding current trading prices, SMMT is priced at $13.94, while SRRK trades at $49.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas SRRK's P/E ratio is -13.72. In terms of profitability, SMMT's ROE is -3.41%, compared to SRRK's ROE of -1.64%. Regarding short-term risk, SMMT is less volatile compared to SRRK. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check SRRK's competition here
SMMT vs CDTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, SMMT is priced at $13.94, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CDTX's P/E ratio is -19.77. In terms of profitability, SMMT's ROE is -3.41%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, SMMT is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CDTX's competition here
SMMT vs APGE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, APGE has a market cap of 5.6B. Regarding current trading prices, SMMT is priced at $13.94, while APGE trades at $132.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas APGE's P/E ratio is -20.87. In terms of profitability, SMMT's ROE is -3.41%, compared to APGE's ROE of -0.33%. Regarding short-term risk, SMMT is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check APGE's competition here
SMMT vs ABCM Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, SMMT is priced at $13.94, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, SMMT's ROE is -3.41%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, SMMT is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ABCM's competition here
SMMT vs ISEE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, SMMT is priced at $13.94, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ISEE's P/E ratio is -22.44. In terms of profitability, SMMT's ROE is -3.41%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, SMMT is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ISEE's competition here
SMMT vs LGND Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, LGND has a market cap of 5.5B. Regarding current trading prices, SMMT is priced at $13.94, while LGND trades at $252.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas LGND's P/E ratio is 35.84. In terms of profitability, SMMT's ROE is -3.41%, compared to LGND's ROE of +0.16%. Regarding short-term risk, SMMT is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check LGND's competition here
SMMT vs CGON Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CGON has a market cap of 5.4B. Regarding current trading prices, SMMT is priced at $13.94, while CGON trades at $64.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CGON's P/E ratio is -26.10. In terms of profitability, SMMT's ROE is -3.41%, compared to CGON's ROE of -0.23%. Regarding short-term risk, SMMT is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check CGON's competition here
SMMT vs MIRM Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, MIRM has a market cap of 5.4B. Regarding current trading prices, SMMT is priced at $13.94, while MIRM trades at $108.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas MIRM's P/E ratio is -7.88. In terms of profitability, SMMT's ROE is -3.41%, compared to MIRM's ROE of -2.89%. Regarding short-term risk, SMMT is less volatile compared to MIRM. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check MIRM's competition here
SMMT vs SYRE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, SYRE has a market cap of 5.3B. Regarding current trading prices, SMMT is priced at $13.94, while SYRE trades at $98.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas SYRE's P/E ratio is -41.67. In terms of profitability, SMMT's ROE is -3.41%, compared to SYRE's ROE of -0.31%. Regarding short-term risk, SMMT is less volatile compared to SYRE. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check SYRE's competition here
SMMT vs FBIOX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, FBIOX has a market cap of 5.3B. Regarding current trading prices, SMMT is priced at $13.94, while FBIOX trades at $26.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas FBIOX's P/E ratio is N/A. In terms of profitability, SMMT's ROE is -3.41%, compared to FBIOX's ROE of N/A. Regarding short-term risk, SMMT is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check FBIOX's competition here
SMMT vs APLS Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, APLS has a market cap of 5.3B. Regarding current trading prices, SMMT is priced at $13.94, while APLS trades at $41.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas APLS's P/E ratio is 38.35. In terms of profitability, SMMT's ROE is -3.41%, compared to APLS's ROE of +0.40%. Regarding short-term risk, SMMT is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check APLS's competition here
SMMT vs CAI Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CAI has a market cap of 5.2B. Regarding current trading prices, SMMT is priced at $13.94, while CAI trades at $17.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CAI's P/E ratio is -6.69. In terms of profitability, SMMT's ROE is -3.41%, compared to CAI's ROE of +0.06%. Regarding short-term risk, SMMT is less volatile compared to CAI. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check CAI's competition here
SMMT vs CRSP Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CRSP has a market cap of 5.2B. Regarding current trading prices, SMMT is priced at $13.94, while CRSP trades at $54.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CRSP's P/E ratio is -8.77. In terms of profitability, SMMT's ROE is -3.41%, compared to CRSP's ROE of -0.31%. Regarding short-term risk, SMMT is more volatile compared to CRSP. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CRSP's competition here
SMMT vs LEGN Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, LEGN has a market cap of 5.2B. Regarding current trading prices, SMMT is priced at $13.94, while LEGN trades at $28.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas LEGN's P/E ratio is -20.24. In terms of profitability, SMMT's ROE is -3.41%, compared to LEGN's ROE of -0.25%. Regarding short-term risk, SMMT is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check LEGN's competition here
SMMT vs TVTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, TVTX has a market cap of 5.1B. Regarding current trading prices, SMMT is priced at $13.94, while TVTX trades at $56.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas TVTX's P/E ratio is -110.30. In terms of profitability, SMMT's ROE is -3.41%, compared to TVTX's ROE of -0.27%. Regarding short-term risk, SMMT is more volatile compared to TVTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check TVTX's competition here
SMMT vs TERN Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, TERN has a market cap of 4.8B. Regarding current trading prices, SMMT is priced at $13.94, while TERN trades at $52.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas TERN's P/E ratio is -51.41. In terms of profitability, SMMT's ROE is -3.41%, compared to TERN's ROE of -0.20%. Regarding short-term risk, SMMT is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check TERN's competition here
SMMT vs FOLD Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, SMMT is priced at $13.94, while FOLD trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas FOLD's P/E ratio is -161.00. In terms of profitability, SMMT's ROE is -3.41%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, SMMT is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check FOLD's competition here
SMMT vs AKRO Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, SMMT is priced at $13.94, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas AKRO's P/E ratio is -14.57. In terms of profitability, SMMT's ROE is -3.41%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, SMMT is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check AKRO's competition here
SMMT vs ALPN Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, SMMT is priced at $13.94, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ALPN's P/E ratio is -101.52. In terms of profitability, SMMT's ROE is -3.41%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, SMMT is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ALPN's competition here
SMMT vs CELC Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CELC has a market cap of 4.3B. Regarding current trading prices, SMMT is priced at $13.94, while CELC trades at $87.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CELC's P/E ratio is -22.50. In terms of profitability, SMMT's ROE is -3.41%, compared to CELC's ROE of -2.45%. Regarding short-term risk, SMMT is more volatile compared to CELC. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CELC's competition here
SMMT vs VCYT Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, VCYT has a market cap of 4.3B. Regarding current trading prices, SMMT is priced at $13.94, while VCYT trades at $52.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas VCYT's P/E ratio is 49.66. In terms of profitability, SMMT's ROE is -3.41%, compared to VCYT's ROE of +0.07%. Regarding short-term risk, SMMT is less volatile compared to VCYT. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check VCYT's competition here
SMMT vs ERAS Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ERAS has a market cap of 4.3B. Regarding current trading prices, SMMT is priced at $13.94, while ERAS trades at $14.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ERAS's P/E ratio is -14.70. In terms of profitability, SMMT's ROE is -3.41%, compared to ERAS's ROE of -0.77%. Regarding short-term risk, SMMT is less volatile compared to ERAS. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check ERAS's competition here
SMMT vs OPT Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, SMMT is priced at $13.94, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas OPT's P/E ratio is -1.52. In terms of profitability, SMMT's ROE is -3.41%, compared to OPT's ROE of +1.09%. Regarding short-term risk, SMMT is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check OPT's competition here
SMMT vs XENE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, XENE has a market cap of 4.2B. Regarding current trading prices, SMMT is priced at $13.94, while XENE trades at $54.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas XENE's P/E ratio is -11.26. In terms of profitability, SMMT's ROE is -3.41%, compared to XENE's ROE of -0.49%. Regarding short-term risk, SMMT is less volatile compared to XENE. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check XENE's competition here
SMMT vs KNSA Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, KNSA has a market cap of 4.1B. Regarding current trading prices, SMMT is priced at $13.94, while KNSA trades at $56.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas KNSA's P/E ratio is 60.56. In terms of profitability, SMMT's ROE is -3.41%, compared to KNSA's ROE of +0.13%. Regarding short-term risk, SMMT is more volatile compared to KNSA. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check KNSA's competition here
SMMT vs MRTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, SMMT is priced at $13.94, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas MRTX's P/E ratio is -4.82. In terms of profitability, SMMT's ROE is -3.41%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, SMMT is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check MRTX's competition here
SMMT vs EWTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, EWTX has a market cap of 4B. Regarding current trading prices, SMMT is priced at $13.94, while EWTX trades at $36.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas EWTX's P/E ratio is -22.17. In terms of profitability, SMMT's ROE is -3.41%, compared to EWTX's ROE of -0.33%. Regarding short-term risk, SMMT is less volatile compared to EWTX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check EWTX's competition here
SMMT vs MANE Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, MANE has a market cap of 3.9B. Regarding current trading prices, SMMT is priced at $13.94, while MANE trades at $102.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas MANE's P/E ratio is -35.42. In terms of profitability, SMMT's ROE is -3.41%, compared to MANE's ROE of -0.95%. Regarding short-term risk, SMMT is less volatile compared to MANE. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check MANE's competition here
SMMT vs CPRX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CPRX has a market cap of 3.8B. Regarding current trading prices, SMMT is priced at $13.94, while CPRX trades at $31.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CPRX's P/E ratio is 18.14. In terms of profitability, SMMT's ROE is -3.41%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, SMMT is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CPRX's competition here
SMMT vs CRNX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CRNX has a market cap of 3.8B. Regarding current trading prices, SMMT is priced at $13.94, while CRNX trades at $36.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CRNX's P/E ratio is -6.98. In terms of profitability, SMMT's ROE is -3.41%, compared to CRNX's ROE of -0.44%. Regarding short-term risk, SMMT is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check CRNX's competition here
SMMT vs RYZB Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, SMMT is priced at $13.94, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas RYZB's P/E ratio is -57.86. In terms of profitability, SMMT's ROE is -3.41%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, SMMT is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check RYZB's competition here
SMMT vs CBAY Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, SMMT is priced at $13.94, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas CBAY's P/E ratio is -32.81. In terms of profitability, SMMT's ROE is -3.41%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, SMMT is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check CBAY's competition here
SMMT vs ACAD Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, ACAD has a market cap of 3.7B. Regarding current trading prices, SMMT is priced at $13.94, while ACAD trades at $21.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas ACAD's P/E ratio is 9.78. In terms of profitability, SMMT's ROE is -3.41%, compared to ACAD's ROE of +0.36%. Regarding short-term risk, SMMT is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check ACAD's competition here
SMMT vs DNLI Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, DNLI has a market cap of 3.7B. Regarding current trading prices, SMMT is priced at $13.94, while DNLI trades at $23.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas DNLI's P/E ratio is -8.09. In terms of profitability, SMMT's ROE is -3.41%, compared to DNLI's ROE of -0.52%. Regarding short-term risk, SMMT is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check DNLI's competition here
SMMT vs SWTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, SMMT is priced at $13.94, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas SWTX's P/E ratio is -13.78. In terms of profitability, SMMT's ROE is -3.41%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, SMMT is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check SWTX's competition here
SMMT vs VKTX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, VKTX has a market cap of 3.5B. Regarding current trading prices, SMMT is priced at $13.94, while VKTX trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas VKTX's P/E ratio is -7.32. In terms of profitability, SMMT's ROE is -3.41%, compared to VKTX's ROE of -0.71%. Regarding short-term risk, SMMT is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check VKTX's competition here
SMMT vs NAMSW Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, NAMSW has a market cap of 3.5B. Regarding current trading prices, SMMT is priced at $13.94, while NAMSW trades at $18.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas NAMSW's P/E ratio is N/A. In terms of profitability, SMMT's ROE is -3.41%, compared to NAMSW's ROE of -0.30%. Regarding short-term risk, SMMT is more volatile compared to NAMSW. This indicates potentially higher risk in terms of short-term price fluctuations for SMMT.Check NAMSW's competition here
SMMT vs BEAM Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, BEAM has a market cap of 3.5B. Regarding current trading prices, SMMT is priced at $13.94, while BEAM trades at $35.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas BEAM's P/E ratio is -69.67. In terms of profitability, SMMT's ROE is -3.41%, compared to BEAM's ROE of -0.06%. Regarding short-term risk, SMMT is less volatile compared to BEAM. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check BEAM's competition here
SMMT vs NAMS Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, NAMS has a market cap of 3.5B. Regarding current trading prices, SMMT is priced at $13.94, while NAMS trades at $30.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas NAMS's P/E ratio is -16.76. In terms of profitability, SMMT's ROE is -3.41%, compared to NAMS's ROE of -0.30%. Regarding short-term risk, SMMT is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check NAMS's competition here
SMMT vs TNGX Comparison June 2026
SMMT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SMMT stands at 10.7B. In comparison, TNGX has a market cap of 3.5B. Regarding current trading prices, SMMT is priced at $13.94, while TNGX trades at $28.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SMMT currently has a P/E ratio of -8.65, whereas TNGX's P/E ratio is -33.70. In terms of profitability, SMMT's ROE is -3.41%, compared to TNGX's ROE of -0.42%. Regarding short-term risk, SMMT is less volatile compared to TNGX. This indicates potentially lower risk in terms of short-term price fluctuations for SMMT.Check TNGX's competition here